Skip to Main Content U.S. Department of Energy
Fundamental and Computational Sciences Directorate

Staff information

Chelsea Hutchinson Bunch

Biosample Pipeline
Chemist
Pacific Northwest National Laboratory
PO Box 999
MSIN: J4-02
Richland, WA 99352

PNNL Publications

2025

  • Pino M.F., P. Dijkstra, K. Whytock, C. Ahn, G. Yu, J.A. Sanford, and J.R. Hansen, et al. 2025. "Exercise alters molecular profiles of inflammation and substrate metabolism in human white adipose tissue." American Journal of Physiology: Endocrinology and Metabolism 328, no. 3:E478-E492. PNNL-SA-203558. doi:10.1152/ajpendo.00339.2024

2024

  • Berrios L., G.D. Bogar, L. Bogar, A. Monterio Venturini, C.E. Willing, A.A. Del Rio, and T. Ansell, et al. 2024. "Ectomycorrhizal fungi alter soil food webs and the functional potential of bacteria communities." mSystems 9, no. 6:Art. No. e00369-24. PNNL-SA-192775. doi:10.1128/msystems.00369-24
  • Modak R.V., K. Rebola, J. Mcclatchy, M. Mohammadhosseini, A. Damnernsawad, S.E. Kurtz, and C.A. Eide, et al. 2024. "Targeting CCL2/CCR2 signaling overcomes MEK inhibitor resistance in Acute Myeloid Leukemia." Clinical Cancer Research 30, no. 10:2245 - 2259. PNNL-SA-187155. doi:10.1158/1078-0432.CCR-23-2654
  • Pino J.C., J.C. Posso Escobar, S.K. Joshi, M.D. Nestor, J. Moon, J.R. Hansen, and C.M. Hutchinson, et al. 2024. "Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia." Cell Reports Medicine 5, no. 1:Art. No. 101359. PNNL-SA-185276. doi:10.1016/j.xcrm.2023.101359

2023

  • Leiser O.P., D.L. Auberry, E. Bakker, W.B. Chrisler, K.M. Engbrecht, H.E. Engelmann, and S.J. Fansler, et al. 2023. "Insights from a workplace SARS-CoV-2 specimen collection program, with genomes placed into global sequence phylogeny." PLoS One 18, no. 4:Art. No. e0285042. PNNL-SA-179220. doi:10.1371/journal.pone.0285042

2022

  • Gosline S., C.E. Tognon, M.D. Nestor, S.K. Joshi, R.V. Modak, A. Damnernsawad, and J.C. Posso Escobar, et al. 2022. "Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML." Clinical Proteomics 19. PNNL-SA-163043. doi:10.1186/s12014-022-09367-9

2021

  • Chroumpi T., M. Peng, L. Markillie, H.D. Mitchell, C.D. Nicora, C.M. Hutchinson, and V.L. Paurus, et al. 2021. "Re-routing of sugar catabolism provides a better insight into fungal flexibility in using plant biomass-derived monomers as substrates." Frontiers in Bioengineering and Biotechnology 9. PNNL-SA-158642. doi:10.3389/fbioe.2021.644216
  • Joshi S.K., T. Nechiporuk, D. Bottomly, P.D. Piehowski, J. Reisz, J. Pittsenbarger, and A. Kaempf, et al. 2021. "The AML microenvironment catalyzes a step-wise evolution to gilteritinib resistance." Cancer Cell 39, no. 7:999-1014. PNNL-SA-161620. doi:10.1016/j.ccell.2021.06.003

2020

  • Sanford J.A., C.D. Nogiec, M.E. Lindholm, J.N. Adkins, D. Amar, S. Dasari, and J.K. Drugan, et al. 2020. "Molecular Transducers of Physical Activity Consortium (MoTrPAC): Mapping the Dynamic Responses to Exercise." Cell 181, no. 7:1464-1474. PNNL-SA-155782. doi:10.1016/j.cell.2020.06.004

Science at PNNL

Core Research Areas

User Facilities

Centers & Institutes

Research Highlights

View All Research Highlights & Staff Accomplishments

RSS Feed

Contacts